Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 383.50
Bid: 388.00
Ask: 390.00
Change: -4.50 (-1.16%)
Spread: 2.00 (0.515%)
Open: 392.50
High: 393.00
Low: 383.50
Prev. Close: 388.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stress test results

2 Nov 2018 17:15

RNS Number : 2556G
Banco Santander S.A.
02 November 2018
 

 

 

 

 

 

 

 

 

MATERIAL FACT

 

Banco Santander, S.A. ("Santander") announces the results it has obtained in the latest stress test exercise carried out by the European Banking Authority (EBA) and the European Central Bank (ECB).

 

The exercise covered a three-year period (end of 2017 - end of 2020), with two scenarios (baseline and adverse) applied to the entire consolidated perimeter of the Santander Group.

 

Santander's results were as follows:

 

· Under the adverse scenario, Santander Group's fully loaded CET1 ratio (i.e. including the full impact of CRR/CRD and IFRS 9) would decrease by 1.41 percentage points to 9.20% as of 31 December 2020, from the starting point of 10.61% as of 31 December 2017. Under the same scenario, the Group's phased-in CET1 ratio (i.e. adopting the CRR/CRD and IFRS 9 transitional arrangements) would decrease by 2.59 percentage points to 9.72% as of 31 December 2020, from the starting point of 12.31%.

· Under the baseline scenario, Santander Group's fully loaded CET1 ratio (i.e. including the full impact of CRR/CRD and IFRS 9 and without adopting the CRR/CRD and IFRS 9 transitional arrangements) would increase by 3.26 percentage points to 13.87% as of 31 December 2020. Under the same scenario, the phased-in CET1 ratio (i.e. adopting the CRR/CRD and IFRS 9 transitional arrangements) would increase by 1.76 percentage points to 14.07%.

 

 

Boadilla del Monte (Madrid), 2 November 2018

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAXFAEFAPFFF
Date   Source Headline
30th Mar 20223:00 pmRNSForm 8.3 - Meggitt Plc
25th Mar 20222:29 pmRNSForm 8.3 - Meggitt plc
25th Mar 20222:27 pmRNSForm 8.3 - Clinigen Group plc
25th Mar 202212:51 pmRNSForm 8.3 - Ultra Electronics Holdings plc
24th Mar 202212:10 pmRNSBuyback programme: transactions 5 - 23 March
15th Mar 202212:40 pmRNSForm 8.3 - Meggitt plc
14th Mar 202211:51 amRNSCommencement of a program to repurchase own shares
9th Mar 202210:04 amRNSForm 8.3 - Meggitt Plc
3rd Mar 202211:58 amRNSForm 8.3 - Spectris plc
3rd Mar 202211:53 amRNSForm 8.3 - Oxford Instruments plc
1st Mar 20224:18 pmRNSOptional early redemption ISIN XS1602466424
28th Feb 202212:22 pmRNSDirector/PDMR Shareholding
28th Feb 20227:00 amRNSNotice of AGM
25th Feb 202211:33 amRNSForm 8.3 - Ultra Electronics Holdings plc
24th Feb 20225:35 pmRNSNotice of AGM
24th Feb 20222:49 pmRNSFurther re dividend declaration
24th Feb 20222:34 pmRNSDividend Declaration
18th Feb 202211:04 amRNSForm 8.3 - Meggitt plc
18th Feb 202210:55 amRNSForm 8.3 - Ultra Electronics Holdings plc
18th Feb 202210:47 amRNSForm 8.3 - Sanne Group plc
17th Feb 202210:54 amRNSForm 8.3 - Meggitt Plc
17th Feb 202210:49 amRNSForm 8.3 - Avast Plc
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
16th Feb 20223:20 pmRNSForm 8.3 - Meggitt Plc
16th Feb 20223:18 pmRNSForm 8.3 - Avast Plc
15th Feb 20229:07 amRNSForm 8.3 - Sanne Group plc
10th Feb 202211:37 amRNSForm 8.3 - Avast Plc
7th Feb 20224:43 pmRNSDirector/PDMR Shareholding
3rd Feb 20222:41 pmRNSSREP Capital Requirements 2022
2nd Feb 20228:25 amRNSForm 8.3 - Avast plc
2nd Feb 20227:00 amRNS2021 results report & analyst presentation
2nd Feb 20227:00 amRNS2021 Results - Press release
1st Feb 20223:03 pmRNSNotice of 2021 Results
1st Feb 20229:22 amRNSForm 8.3 - Avast Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.